GlassScriptPhysician profile
Henry G Raroque
NPI 1023077567
$9,243.43
in general payments reported to CMS, 2019-2025
55 companies · $730 in 2025
The $730 reported for 2025 was more than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,843 · 2020: $582 · 2021: $771 · 2022: $1,477 · 2023: $2,468 · 2024: $1,371 · 2025: $730.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,419 · Education: $151.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,418.69 |
| Education | $150.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,210.04 | 2021-2025 | |
| Jazz Pharmaceuticals INC. | $760.03 | 2019-2024 | |
| Teva Pharmaceuticals USA, INC. | $635.39 | 2019-2024 | Ajovy |
| Harmony Biosciences LLC | $617.99 | 2020-2025 | Wakix |
| Ucb, INC. | $569.45 | 2019-2024 | Briviact |
| Lilly USA, LLC | $504.44 | 2019-2024 | Amyvid, Emgality |
| Pfizer INC. | $491.91 | 2023-2025 | |
| Emd Serono, INC. | $321.38 | 2019-2022 | |
| Sk Life Science, INC. | $310.11 | 2021-2023 | Xcopri |
| Inspire Medical Systems, INC. | $264.55 | 2023-2025 | Inspire |
| Genzyme Corporation | $250.43 | 2019-2023 | |
| Axsome Therapeutics, INC. | $249.19 | 2023-2025 | Sunosi, Symbravo |
| Amgen INC. | $241.13 | 2019-2025 | Uplizna |
| Novartis Pharmaceuticals Corporation | $239.97 | 2019-2024 | |
| Allergan, INC. | $216.22 | 2019-2021 |
Show all 55 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Henry Raroque listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.